8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 13, 2005

Commission File No. 001-12392

NDCHealth Corporation

(Exact name of registrant as specified in its charter)

DELAWARE	58-0977458
(State or other jurisdiction of incorporation)	(IRS Employer Identification Number)

NDC Plaza, Atlanta, Georgia	30329-2010
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code (404) 728-2000

None

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 8.01 Other Events.

On January 13, 2005, the Board of Directors of NDCHealth Corporation (“NDCHealth” or the “Company”) issued a press release announcing that an independent committee of the Board had completed its review of candidates and will engage a leading investment banking firm from its final list of candidates to analyze and report to the Board on strategic alternatives for the Company to maximize stockholder value.

A copy of the press release issued by the Company is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits.

(c) Exhibits.

Exhibit Number	Exhibit Title
99.1	Press Release dated January 13, 2005.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NDCHealth Corporation
(Registrant)
By:	/s/ Lee Adrean
	Lee Adrean
	Chief Financial Officer

Date: January 13, 2005

EX-99.1

Exhibit 99.1

NDC Plaza

Atlanta, GA 30329-2010

404-728-2000

For Immediate Release

NDCHealth Board to Evaluate Strategic Alternatives

ATLANTA, January 13, 2005 – The Board of Directors of NDCHealth Corporation (NYSE: NDC) announced today that a committee of independent directors completed its review of candidates and will engage a leading investment banking firm from its final list of candidates to analyze and report to the Board on strategic alternatives.

With assistance from the investment bank, the Board will evaluate the company’s strategic alternatives with the objective of maximizing stockholder value. More specifically, the Board will carefully weigh the impact of management’s initiatives to deliver improved revenue and profit performance, and a full range of strategic alternatives including, but not limited to, divestitures, recapitalizations, alliances with strategic partners, and a sale to or merger with a third party.

About NDCHealth

NDCHealth is uniquely positioned in healthcare as a leading provider of point-of-service systems, electronic connectivity and information solutions to pharmacies, hospitals and health facilities, physicians, pharmaceutical manufacturers and payers.

Safe Harbor Statement

NDCHealth notes that there can be no assurance that any corporate action will result from this evaluation. While the company may, from time to time, make further announcements, it assumes no obligation to make any further announcements regarding its exploration of strategic alternatives until such time as any decision or decisions are made.

###

Contact:

Robert Borchert

VP, Investor Relations

404-728-2906

robert.borchert@ndchealth.com